The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
basically any nonHDL cholesterol that is under 70 nmters in diameter which uh VLDLS can fall into that LDL obviously falls into that. IDL's can fall into that depending on the IDL. But basically any lipoprotein that contains an APOB molecule or an APOB protein that is that the lipoprotein is under 70 nmters in diameter can penetrate the endothelium.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.